ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,841Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 180

$1.31M Total Retail Price of All Prescriptions

Rank: 3 out of 180

816 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,798 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 661 463 1 6
OMEPRAZOLE 609 434 2 2
PRAVASTATIN SODIUM 559 426 3 17
HYDROCODONE-ACETAMINOPHEN 549 343 S3 4 1
POTASSIUM CHLORIDE 547 468 5 13
FUROSEMIDE 517 437 6 5
SIMVASTATIN 455 386 7 9
LISINOPRIL 447 381 8 3
SPIRONOLACTONE 418 278 9 69
GABAPENTIN 374 301 10 10
METOPROLOL TARTRATE 371 317 11 11
AMLODIPINE BESYLATE 365 323 12 7
METFORMIN HCL 332 258 13 14
WARFARIN SODIUM 331 297 14 12
LOSARTAN POTASSIUM 267 232 15 23
LOVASTATIN 242 180 16 32
ZOLPIDEM TARTRATE 240 134 17 28
CITALOPRAM HBR 233 183 18 22
CRESTOR 232 149 19 62
ISOSORBIDE MONONITRATE ER 229 183 20 26
TRAMADOL HCL 222 165 21 16
CARVEDILOL 210 185 22 15
PANTOPRAZOLE SODIUM 207 145 23 40
FENOFIBRATE 204 150 24 108
ATENOLOL 190 170 25 35
MELOXICAM 187 135 26 27
METOPROLOL SUCCINATE 183 146 27 25
ENALAPRIL MALEATE 177 118 28 98
HYDROCHLOROTHIAZIDE 172 152 29 19
CLOPIDOGREL 170 112 30 24
POLYETHYLENE GLYCOL 3350 164 72 31 89
ATORVASTATIN CALCIUM 162 141 32 39
CIPROFLOXACIN HCL 155 105 33 21
CYMBALTA 152 90 34 58
TRAZODONE HCL 150 99 35 33
GLIMEPIRIDE 148 129 36 77
DEXAMETHASONE 146 114 37 229
SERTRALINE HCL 143 82 38 46
NEXIUM 141 82 39 54
ROPINIROLE HCL 140 95 40 82
ALENDRONATE SODIUM 132 112 41 76
MIRTAZAPINE 125 103 42 48
LOVAZA 117 67 43 192
DOXYCYCLINE HYCLATE 115 64 44 45
LANTUS 114 93 45 37
CLONIDINE HCL 113 93 46 67
ALLOPURINOL 109 89 47 43
PLAVIX 106 73 48 38
DONEPEZIL HCL 104 99 49 34
OXYCODONE HCL-ACETAMINOPHEN 104 45 S2 49 75
CEPHALEXIN 104 83 49 55
RISPERIDONE 103 70 52 80
TORSEMIDE 103 67 52 140
RANITIDINE HCL 103 69 52 18
FENTANYL 101 66 S2 55 107
AZITHROMYCIN 100 78 56 61
PAROXETINE HCL 99 93 57 113
LEVETIRACETAM 98 78 58 36
ALPRAZOLAM 97 85 59 265
METOCLOPRAMIDE HCL 97 53 59 123
FLUTICASONE PROPIONATE 97 74 59 30
NAMENDA 96 74 62 44
BUMETANIDE 96 82 62 166
LOSARTAN-HYDROCHLOROTHIAZIDE 96 93 62 199
PROAIR HFA 96 52 62 59
DILTIAZEM 24HR CD 95 88 66 128
TAMSULOSIN HCL 95 84 66 4
SPIRIVA 93 64 68 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 63 69 141
CYCLOBENZAPRINE HCL 91 43 R 70 60
ZETIA 89 81 71 176
BUSPIRONE HCL 86 61 72 93
KLOR-CON M20 86 85 72 132
CARISOPRODOL 83 40 R 74 87
WELCHOL 82 67 75 236
LEVOFLOXACIN 82 53 75 143
DIGOXIN 81 74 77 49
FAMOTIDINE 80 59 78 106
AMIODARONE HCL 78 74 79 137
TIZANIDINE HCL 78 44 79 136
TRICOR 77 53 81 200
PREDNISONE 76 46 82 47
SINGULAIR 76 43 82 105
DILTIAZEM HCL 74 53 84 179
LIDODERM 74 58 84 154
JANUVIA 73 33 86 97
GLYBURIDE-METFORMIN HCL 73 73 R 86 283
FLUOXETINE HCL 69 37 88 71
NIASPAN 69 14 88 194
BYSTOLIC 67 48 90 111
MIDODRINE HCL 64 25 91 297
NITROFURANTOIN 63 53 92 130
TOPIRAMATE 63 22 92 53
GLIPIZIDE 63 63 92 86
ABILIFY 63 40 92 209
SYMBICORT 62 51 96 127
CARBIDOPA-LEVODOPA 62 55 96 68
HYDROXYZINE HCL 61 45 R 98 249
MONTELUKAST SODIUM 60 35 99 204
OXYCODONE-ACETAMINOPHEN 59 34 S2 100 73
SYNTHROID 59 55 100 178
PHENYTOIN SODIUM EXTENDED 58 24 102 109
QUETIAPINE FUMARATE 58 28 102 94
OXYBUTYNIN CHLORIDE 57 57 104 82
LYRICA 57 21 104 81
ADVAIR DISKUS 56 43 106 72
LANTUS SOLOSTAR 56 51 106 142
COMBIVENT 56 36 106 170
GEMFIBROZIL 55 49 109 168
PROMETHAZINE VC 55 33 R 109 320
ONGLYZA 54 49 111 220
FINASTERIDE 54 54 111 8
PEN NEEDLE 54 40 111 114
ZENPEP 54 38 111 327
AMPHETAMINE SALT COMBO 53 0 S2 115 224
AMITRIPTYLINE HCL 53 43 R 115 57
CILOSTAZOL 52 37 117 198
DICYCLOMINE HCL 51 32 118 162
HYDROCODONE BIT-IBUPROFEN 50 29 S3 119 346
DIOVAN 50 48 119 96
FLUCONAZOLE 50 33 119 188
VESICARE 50 48 119 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.